FDA
approval
· 2021-08-23
FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
Summary
The FDA approved a supplemental application for Buprenorphine and Naloxone from Sun Pharmaceutical Industries, Inc., updating the product's status related to op…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)